Literature DB >> 15801687

Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes--a brief report.

Jørgen Vesti Nielsen1, Eva Jönsson, Anna-Karin Nilsson.   

Abstract

UNLABELLED: In two groups of obese patients with type 2 diabetes the effects of 2 different diet compositions were tested with regard to glycaemic control and bodyweight. A group of 16 obese patients with type 2 diabetes was advised on a low-carbohydrate diet, 1800 kcal for men and 1600 kcal for women, distributed as 20 % carbohydrates, 30 % protein and 50 % fat. Fifteen obese diabetes patients on a high-carbohydrate diet were control group. Their diet, 1600-1800 kcal for men and 1400-1600 kcal for women, consisted of approximately 60 % carbohydrates, 15 % protein and 25 % fat. Positive effects on the glucose levels were seen very soon. After 6 months a marked reduction in bodyweight of patients in the low-carbohydrate diet group was observed, and this remained one year later. After 6 months the mean changes in the low-carbohydrate group and the control group respectively were (+/-SD): fasting blood glucose (f-BG): -3.4+/-2.9 and -0.6+/-2.9 mmol/l; HBA1c: -1.4+/-1.1 % and -0.6+/-1.4 %; Body Weight: -11.4+/-4 kg and -1.8+/-3.8 kg; BMI: -4.1+/-1.3 kg/m_ and -0.7+/-1.3 kg/m_. Large changes in blood glucose levels were seen immediately.
CONCLUSION: A low-carbohydrate diet is an effective tool in the treatment of obese patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801687     DOI: 10.3109/2000-1967-182

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  8 in total

Review 1.  Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.

Authors:  Celeste E Naude; Amanda Brand; Anel Schoonees; Kim A Nguyen; Marty Chaplin; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2022-01-28

2.  A low-carbohydrate diet may prevent end-stage renal failure in type 2 diabetes. A case report.

Authors:  Jørgen Vesti Nielsen; Per Westerlund; Per Bygren
Journal:  Nutr Metab (Lond)       Date:  2006-06-14       Impact factor: 4.169

3.  The case for low carbohydrate diets in diabetes management.

Authors:  Surender K Arora; Samy I McFarlane
Journal:  Nutr Metab (Lond)       Date:  2005-07-14       Impact factor: 4.169

Review 4.  Low Carbohydrate and Low-Fat Diets: What We Don't Know and Why we Should Know It.

Authors:  Heather Seid; Michael Rosenbaum
Journal:  Nutrients       Date:  2019-11-12       Impact factor: 5.717

Review 5.  Dietary advice for treatment of type 2 diabetes mellitus in adults.

Authors:  L Nield; H J Moore; L Hooper; J K Cruickshank; A Vyas; V Whittaker; C D Summerbell
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

6.  Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal.

Authors:  Anthony Accurso; Richard K Bernstein; Annika Dahlqvist; Boris Draznin; Richard D Feinman; Eugene J Fine; Amy Gleed; David B Jacobs; Gabriel Larson; Robert H Lustig; Anssi H Manninen; Samy I McFarlane; Katharine Morrison; Jørgen Vesti Nielsen; Uffe Ravnskov; Karl S Roth; Ricardo Silvestre; James R Sowers; Ralf Sundberg; Jeff S Volek; Eric C Westman; Richard J Wood; Jay Wortman; Mary C Vernon
Journal:  Nutr Metab (Lond)       Date:  2008-04-08       Impact factor: 4.169

Review 7.  Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis.

Authors:  Celeste E Naude; Anel Schoonees; Marjanne Senekal; Taryn Young; Paul Garner; Jimmy Volmink
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

8.  Impact of Carbohydrate on Glucose Variability in Patients with Type 1 Diabetes Assessed Through Professional Continuous Glucose Monitoring: A Retrospective Study.

Authors:  Yi-Hsuan Lin; Yu-Yao Huang; Hsin-Yun Chen; Sheng-Hwu Hsieh; Jui-Hung Sun; Szu-Tah Chen; Chia-Hung Lin
Journal:  Diabetes Ther       Date:  2019-10-28       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.